Kurt Schrader sold Nike Inc (NYSE: NKE)
Kurt Schrader (D-OR), a U.S. Representative, has disclosed 1 trade in Nike Inc (NKE) since 2022, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Kurt Schrader sold $1,001 - $15,000 of Nike Inc (NYSE: NKE) on January 20, 2022. Since that trade, NKE is down -67.92% against the S&P 500 up +75.99%, an outperformance of -143.91%.
Data updated
Kurt Schrader's NKE trades vs the price
NKE is down -67.92% since Kurt Schrader sold on January 20, 2022, versus +75.99% for the S&P 500.
Performance since this trade
All Kurt Schrader NKE trades
Kurt Schrader & NKE trading FAQ
Is it legal for Kurt Schrader to trade Nike Inc (NKE) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Nike Inc (NKE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Kurt Schrader sell NKE?
Kurt Schrader disclosed a sale of $1,001 - $15,000 of Nike Inc (NKE) on January 20, 2022, according to public STOCK Act filings.
How has NKE performed since Kurt Schrader's trade?
Since Kurt Schrader sold NKE on January 20, 2022, the stock is down -67.92%, versus +75.99% for the S&P 500 over the same period, an outperformance of -143.91%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NKE trades?
Quantellect tracks every disclosed congressional trade in Nike Inc (NKE) on the Nike Inc congressional trading page, which aggregates filings across all members of Congress.
Kurt Schrader's NKE tradesAll congressional filings for Nike IncKurt Schrader's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.